We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LH market cap is 21.39B. The company's latest EPS is USD 8.9128 and P/E is 28.74.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.03B | 3.18B | 3.22B | 3.28B | 3.33B |
| Operating Income | -122.7M | 321.4M | 294.5M | 253.6M | 215.8M |
| Net Income | -167.1M | 228M | 205.3M | 169.3M | 143.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.98B | 16.12B | 14.88B | 12.16B | 13.01B |
| Operating Income | 2.45B | 3.29B | 1.78B | 724.2M | 1.09B |
| Net Income | 1.56B | 2.38B | 1.28B | 418M | 746M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.73B | 16.53B | 16.71B | 18.61B | 18.38B |
| Total Liabilities | 8.83B | 8.56B | 8.69B | 10.43B | 10.31B |
| Total Equity | 7.88B | 7.96B | 8.01B | 8.17B | 8.05B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.07B | 20.39B | 20.16B | 16.73B | 18.38B |
| Total Liabilities | 10.69B | 10.09B | 10.04B | 8.83B | 10.31B |
| Total Equity | 9.36B | 10.27B | 10.1B | 7.88B | 8.05B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.33B | -29.8M | 531.3M | 808.6M | 1.59B |
| Investing | -1.17B | -393.1M | -578.1M | -1.16B | -1.37B |
| Financing | -59.3M | -11.7M | -221.7M | 1.33B | 779.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.14B | 3.11B | 1.96B | 1.33B | 1.59B |
| Investing | -643.2M | -884.6M | -1.65B | -1.17B | -1.37B |
| Financing | -517.4M | -2.07B | -1.32B | -59.3M | 779.9M |
| Market Cap | 21.39B |
| Price to Earnings Ratio | 28.74 |
| Price to Sales Ratio | 1.65 |
| Price to Cash Ratio | 14.12 |
| Price to Book Ratio | 2.66 |
| Dividend Yield | 1.13% |
| Shares Outstanding | 83.7M |
| Average Volume (1 week) | 525.79k |
| Average Volume (1 Month) | 594.74k |
| 52 Week Change | 17.68% |
| 52 Week High | 258.59 |
| 52 Week Low | 191.97 |
| Spread (Intraday) | 0.22 (0.09%) |
| Company Name | Labcorp Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.labcorp.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
